KIMS.NS Balance Sheet
Krishna Institute of Medical Sciences Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:35
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹1,380.58 Cr. | ₹1,730.05 Cr. | ₹2,198.80 Cr. | ₹4,186.20 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹476.93 Cr. | ₹600.09 Cr. | ₹1,213.80 Cr. | ₹606.20 Cr. | CapitalWorkInProgress |
| Goodwill | ₹308.01 Cr. | ₹308.01 Cr. | ₹338.60 Cr. | ₹338.60 Cr. | Goodwill |
| Other Intangible Assets | ₹77.73 Cr. | ₹64.65 Cr. | ₹811.10 Cr. | ₹57.00 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹0.00 Cr. | ₹74.43 Cr. | ₹0.60 Cr. | ₹0.60 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹99.76 Cr. | ₹0.00 Cr. | ₹230.00 Cr. | ₹198.30 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹2,463.66 Cr. | ₹3,259.07 Cr. | ₹5,038.70 Cr. | ₹6,821.30 Cr. | NoncurrentAssets |
| Inventories | ₹42.87 Cr. | ₹49.44 Cr. | ₹64.00 Cr. | ₹96.90 Cr. | Inventories |
| Trade Receivables | ₹252.65 Cr. | ₹294.40 Cr. | ₹395.40 Cr. | ₹554.20 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹61.61 Cr. | ₹46.89 Cr. | ₹56.00 Cr. | ₹55.40 Cr. | CashAndCashEquivalents |
| Current Investments | ₹67.89 Cr. | ₹82.97 Cr. | ₹22.00 Cr. | ₹15.10 Cr. | CurrentInvestments |
| Other Current Assets | ₹11.47 Cr. | ₹35.77 Cr. | ₹37.70 Cr. | ₹56.80 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹477.64 Cr. | ₹592.95 Cr. | ₹697.30 Cr. | ₹937.40 Cr. | CurrentAssets |
| Total Assets | ₹2,941.30 Cr. | ₹3,852.02 Cr. | ₹5,736.00 Cr. | ₹7,758.70 Cr. | Assets |
| Equity Share Capital | ₹80.03 Cr. | ₹80.03 Cr. | ₹80.00 Cr. | ₹80.00 Cr. | EquityShareCapital |
| Other Equity | ₹1,589.51 Cr. | ₹1,748.33 Cr. | ₹2,057.80 Cr. | ₹2,167.40 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹1,669.54 Cr. | ₹1,828.36 Cr. | ₹2,137.80 Cr. | ₹2,247.40 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹268.42 Cr. | ₹264.88 Cr. | ₹281.00 Cr. | ₹311.10 Cr. | NonControllingInterest |
| Total Equity | ₹1,937.96 Cr. | ₹2,093.24 Cr. | ₹2,418.80 Cr. | ₹2,558.50 Cr. | Equity |
| Long-term Borrowings | ₹633.60 Cr. | ₹1,226.30 Cr. | ₹2,287.20 Cr. | ₹2,672.60 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹706.87 Cr. | ₹1,306.49 Cr. | ₹2,481.00 Cr. | ₹3,961.30 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹44.58 Cr. | ₹129.03 Cr. | ₹269.50 Cr. | ₹571.40 Cr. | BorrowingsCurrent |
| Trade Payables | ₹174.25 Cr. | ₹197.15 Cr. | ₹269.10 Cr. | ₹322.80 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹33.12 Cr. | ₹46.36 Cr. | ₹53.80 Cr. | ₹78.00 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹296.47 Cr. | ₹452.29 Cr. | ₹836.20 Cr. | ₹1,238.90 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹2,941.30 Cr. | ₹3,852.02 Cr. | ₹5,736.00 Cr. | ₹7,758.70 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from KIMS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).